PAPER Killick R, Hughes TR, Morgan BP, Lovestone S
SEARCH RESULTS
330986 RESULTS
PAPER Morris MS
The role of B vitamins in preventing and treating cognitive impairment and decline.
Adv Nutr. 2012 Nov;3(6):801-12. PubMed: 23153734PAPER Esteras N, Alquézar C, Bermejo-Pareja F, Bialopiotrowicz E, Wojda U, Martín-Requero A
Downregulation of extracellular signal-regulated kinase 1/2 activity by calmodulin KII modulates p21(Cip1) levels and survival of immortalized lymphocytes from Alzheimer's disease patients.
Neurobiol Aging. 2013 Apr;34(4):1090-100. PubMed: 23153928PAPER Hua X, Hibar DP, Ching CR, Boyle CP, Rajagopalan P, Gutman BA, Leow AD, Toga AW, Jack CR, Harvey D, Weiner MW, Thompson PM,
Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials.
Neuroimage. 2013 Feb 15;66:648-61. PubMed: 23153970PAPER Royall DR, Palmer RF
Alzheimer's disease pathology does not mediate the association between depressive symptoms and subsequent cognitive decline.
Alzheimers Dement. 2012 Nov 13; PubMed: 23154050PAPER Chang RY, Nouwens AS, Dodd PR, Etheridge N
The synaptic proteome in Alzheimer's disease.
Alzheimers Dement. 2012 Nov 13; PubMed: 23154051PAPER Roychaudhuri R, Yang M, Deshpande A, Cole GM, Frautschy S, Lomakin A, Benedek GB, Teplow DB
C-Terminal Turn Stability Determines Assembly Differences between Aβ40 and Aβ42.
J Mol Biol. 2013 Jan 23;425(2):292-308. PubMed: 23154165PAPER Poletti M, Nuti A, Cipriani G, Bonuccelli U
Behavioral and Psychological Symptoms of Dementia: Factor Analysis and Relationship with Cognitive Impairment.
Eur Neurol. 2012 Nov 14;69(2):76-82. PubMed: 23154430PAPER Selvakumar K, Prabha RL, Saranya K, Bavithra S, Krishnamoorthy G, Arunakaran J
Polychlorinated biphenyls impair blood-brain barrier integrity via disruption of tight junction proteins in cerebrum, cerebellum and hippocampus of female Wistar rats: Neuropotential role of quercetin.
Hum Exp Toxicol. 2012 Nov 15; PubMed: 23155198PAPER Park SM, Kim KS
Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease.
Prion. 2012 Nov 15;7(2) PubMed: 23154633PAPER Nakamura K, Zhen Zhou X, Ping Lu K
Cis phosphorylated tau as the earliest detectable pathogenic conformation in Alzheimer disease, offering novel diagnostic and therapeutic strategies.
Prion. 2012 Nov 15;7(2) PubMed: 23154634PAPER Kudo W, Petersen RB, Lee HG
Cellular prion protein and Alzheimer disease: Link to oligomeric amyloid-β and neuronal cell death.
Prion. 2012 Nov 15;7(2) PubMed: 23154635PAPER Avrahami L, Farfara D, Shaham-Kol M, Vassar R, Frenkel D, Eldar-Finkelman H
Inhibition of Glycogen Synthase Kinase-3 Ameliorates β-Amyloid Pathology and Restores Lysosomal Acidification and Mammalian Target of Rapamycin Activity in the Alzheimer Disease Mouse Model: IN VIVO AND IN VITRO STUDIES.
J Biol Chem. 2013 Jan 11;288(2):1295-306. PubMed: 23155049PAPER Yan XX, Cai Y, Shelton J, Deng SH, Luo XG, Oddo S, Laferla FM, Cai H, Rose GM, Patrylo PR